New issue explores innovations in cancer treatments, graphene and drug safety updates.
- 42By Stephen Buxser, Ph.D., Nerac Analyst, Originally Published: November 28, 2016 For drugs licensed for sale in the United States, as well as elsewhere in the world, there are requirements for periodic literature updates/reviews. These reviews require resources to capture all scientific publications describing health or safety issues for a particular drug during a specified…
- Exciting Novel, but High-Cost Developments in Cancer Treatment: Immunotherapy continues to advance as a validated approach36By Holly Magna, Ph.D., Nerac Analyst, Originally Published: November 28, 2016 New developments in Immunotherapy continue to advance and show promising results in treatment of a variety of cancers. This article reviews some of the newly marketed therapies and some still in development, as well as their complications, risks and advantages.
- 30New release offers in-depth business perspectives on industry issues, compliance challenges and commercial opportunities authored by Nerac analysts, industry experts Read the full release here.